CALMA B Stock Overview
Calmark Sweden AB (publ) operates as a medical technology company in Sweden and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Calmark Sweden AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.098 |
| 52 Week High | SEK 1.10 |
| 52 Week Low | SEK 0.074 |
| Beta | 1.49 |
| 1 Month Change | -3.37% |
| 3 Month Change | -14.39% |
| 1 Year Change | -80.48% |
| 3 Year Change | -98.81% |
| 5 Year Change | n/a |
| Change since IPO | -98.05% |
Recent News & Updates
Recent updates
Shareholder Returns
| CALMA B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -2.9% | -0.5% | -0.02% |
| 1Y | -80.5% | -8.7% | 9.0% |
Return vs Industry: CALMA B underperformed the Swedish Medical Equipment industry which returned -7.9% over the past year.
Return vs Market: CALMA B underperformed the Swedish Market which returned 6.9% over the past year.
Price Volatility
| CALMA B volatility | |
|---|---|
| CALMA B Average Weekly Movement | 21.9% |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.6% |
| 10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: CALMA B's share price has been volatile over the past 3 months.
Volatility Over Time: CALMA B's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 4 | Camilla Arneving | www.calmark.se |
Calmark Sweden AB (publ) operates as a medical technology company in Sweden and internationally. The company manufactures and sells POC-Analyzer, a reader with a built-in software, analyzes the color change that occurs in the test cassette; and Neo-Bilirubin, a test cassette with a patented filter design that separates the red blood cells from the plasma used in the POC-Analyzer. It also provides a POC test solution for assessing the severity of COVID-19.
Calmark Sweden AB (publ) Fundamentals Summary
| CALMA B fundamental statistics | |
|---|---|
| Market cap | SEK 11.03m |
| Earnings (TTM) | -SEK 22.23m |
| Revenue (TTM) | SEK 136.00k |
81.1x
P/S Ratio-0.5x
P/E RatioIs CALMA B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CALMA B income statement (TTM) | |
|---|---|
| Revenue | SEK 136.00k |
| Cost of Revenue | SEK 1.07m |
| Gross Profit | -SEK 938.00k |
| Other Expenses | SEK 21.30m |
| Earnings | -SEK 22.23m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.20 |
| Gross Margin | -689.71% |
| Net Profit Margin | -16,348.53% |
| Debt/Equity Ratio | 0% |
How did CALMA B perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/03/08 20:41 |
| End of Day Share Price | 2024/03/08 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Calmark Sweden AB (publ) is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Oscar Bergman | Redeye |